rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kelly Blackburn

EVP, Clinical Development

Company insider

Files Form 4 as: EVP, Clinical Development, CervoMed; VP, Clinical Affairs, aTyr Pharma.

Every Form 4 they filed

In numbers

Trades disclosed
11
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
0
First trade
6 May 2015
Last trade
11 Feb 2026
Last filed
13 Feb 2026

Companies traded

Where they are an officer
CRVO CervoMedOfficer · Biotechnology · last 11 Feb 20260 buys · 0 sells
ATYR aTyr PharmaOfficer · Biotechnology · last 28 Mar 20160 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
11 Feb 2026filed 13 Feb 2026CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
11 Feb 2026filed 13 Feb 2026CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
4 Feb 2025filed 14 Feb 2025CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—27,000 at $0.00filing
26 Jan 2024filed 26 Jan 2024CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
15 Sep 2023filed 15 Sep 2023CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
28 Mar 2016filed 30 Mar 2016ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—21,600 at $0.00filing
27 Jan 2016filed 29 Jan 2016ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—18,250 at $0.00filing
4 Jan 2016filed 6 Jan 2016ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—26,470 at $0.00filing
1 Oct 2015filed 5 Oct 2015ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—45,500 at $0.00filing
1 Oct 2015filed 5 Oct 2015ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—11,581 at $0.00filing
6 May 2015filed 8 May 2015ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—34,573filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Brandon YarasChief Financial Officer · Chief Financial Officer at aTYR PHARMA, filing Form 4 there in the last year
Joshua S. BogerDirector and 10% owner · Director and 10% owner at CervoMed, filing Form 4 there in the last year
Frank ZavrlDirector · Director at CervoMed, filing Form 4 there in the last year
Jane H. HollingsworthDirector · Director at CervoMed, filing Form 4 there in the last year
Sylvie GregoireDirector and 10% owner · Director and 10% owner at CervoMed, filing Form 4 there in the last year